About this episode

This episode features discussions on the management and treatment strategies for Chronic Lymphocytic Leukemia with insights from two experts in the field.

Featuring perspectives from Dr John N Allan and Dr Adam Kittai, including the following topics: Introduction (0:00) Current Management of Newly Diagnosed Chronic Lymphocytic Leukemia — Dr Allan (8:47) Noncovalent Bruton Tyrosine Kinase Inhibitors and Other Novel Strategies — Dr Kittai (38:14) CME information and select publications

People in this episode

Host: Dr Neil Love

Guests: Dr John N Allan, Dr Adam Kittai

Topics covered

• Chronic Lymphocytic Leukemia
• Management of Newly Diagnosed CLL
• Bruton Tyrosine Kinase Inhibitors
• Novel Strategies in Oncology
• CME Information

Keywords

• Chronic Lymphocytic Leukemia
• CLL Management
• Bruton Tyrosine Kinase Inhibitors
• Oncology Summit
• CME

Mentioned in this episode

Books & works: Chronic Lymphocytic Leukemia

More episodes of Hematologic Oncology Update

• For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress · July 16, 2026 · 1h 58m
• Novel Therapies for Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 9, 2026 · 1h 57m
• Acute Myeloid Leukemia — Fifth Annual National General Medical Oncology Summit · June 28, 2026 · 52 min
• Myelofibrosis and Systemic Mastocytosis — Fifth Annual National General Medical Oncology Summit · June 24, 2026 · 51 min
• Multiple Myeloma — Fifth Annual National General Medical Oncology Summit · June 18, 2026 · 47 min
• Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit · June 15, 2026 · 1h 60m

Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.